Literature DB >> 15047546

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Ralf R Reinert1, Rudolf Lütticken, Joyce A Sutcliffe, Amelia Tait-Kamradt, Murat Y Cil, Holger M Schorn, André Bryskier, Adnan Al-Lahham.   

Abstract

In a nationwide study in Germany, a total of 381 Streptococcus pyogenes were collected. Erythromycin A-resistant strains were characterized for the underlying resistance genotype, showing 55.6% had the efflux type mef(A), 31.5% had erm(A), and 13.0% had erm(B). A total of 23 different multilocus sequence types were observed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047546      PMCID： PMC375310          DOI： 10.1128/AAC.48.4.1369-1373.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Authors:  M P Montanari; M Mingoia; E Giovanetti; P E Varaldo
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

3.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin.

Authors:  M Arvand; M Hoeck; H Hahn; J Wagner
Journal:  J Antimicrob Chemother       Date:  2000-10       Impact factor: 5.790

5.  Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.

Authors:  C M Brandt; M Honscha; N D Truong; R Holland; B Hövener; A Bryskier; R Lütticken; R R Reinert
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

6.  Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.

Authors:  W H Traub; B Leonhard
Journal:  Chemotherapy       Date:  1997 Jan-Feb       Impact factor: 2.544

7.  Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards.

Authors:  Peter C Fuchs; Arthur L Barry; Steven D Brown
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

8.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

9.  Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.

Authors:  Rafael Cantón; Elena Loza; M Isabel Morosini; Fernando Baquero
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

10.  Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Authors:  Ralf René Reinert; Rudolf Lütticken; André Bryskier; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more
  10 in total

1.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.

Authors:  Stella Z Doktor; Jill M Beyer; Robert K Flamm; Virginia D Shortridge
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway.

Authors:  Claudio Palmieri; Manuela Vecchi; Pia Littauer; Arnfinn Sundsfjord; Pietro E Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting.

Authors:  Karen F McGregor; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.

Authors:  P Littauer; D A Caugant; M Sangvik; E A Høiby; A Sundsfjord; G S Simonsen
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 6.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

7.  Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.

Authors:  Iris Chen; Pakieli Kaufisi; Guliz Erdem
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

8.  Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption.

Authors:  C Silva-Costa; A Friães; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.

Authors:  Surbhi Malhotra-Kumar; Christine Lammens; Sabine Chapelle; Monique Wijdooghe; Jasper Piessens; Koen Van Herck; Herman Goossens
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

10.  Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain.

Authors:  Ana Isabel Vela; Pilar Villalón; Juan Antonio Sáez-Nieto; Gema Chacón; Lucas Domínguez; José Francisco Fernández-Garayzábal
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.